TBPH earnings call for the period ending March 31, 2019.
News & Analysis: Theravance Biopharma
TBPH earnings call for the period ending December 31, 2018.
Theravance Biopharma announced a stock and debt offering that disappointed investors.
A slew of good news sends shares skyward. So what was announced that got investors so excited?
Despite releasing some good news, a rough month for biotech stocks in general crushed the company's stock.
Theravance Biopharma announced that Mylan Inc. has agreed to co-develop TD-4208 and make an equity investment in the company.
Theravance's new structure may surprise investors looking for a pure play.
Do short-sellers have these three stocks pegged? You be the judge!